(E)-(1RS,2SR,3RS,5SR)-7-(4ï-METHOXYCARBONYL)-BUTYL-3-TERT.-BUTYLDIMETHYLSILYLOXY-2-CYANOBICYCLO-[3.3.0]-OCT-7-ENE
Compound with spectra: 1 NMR
![(E)-(1RS,2SR,3RS,5SR)-7-(4ï-METHOXYCARBONYL)-BUTYL-3-TERT.-BUTYLDIMETHYLSILYLOXY-2-CYANOBICYCLO-[3.3.0]-OCT-7-ENE](/api/compound/AaRjkH7b57J.png?ph=true&h=300&w=458 "(E)-(1RS,2SR,3RS,5SR)-7-(4ï-METHOXYCARBONYL)-BUTYL-3-TERT.-BUTYLDIMETHYLSILYLOXY-2-CYANOBICYCLO-[3.3.0]-OCT-7-ENE")
| SpectraBase Compound ID | AaRjkH7b57J |
|---|---|
| InChI | InChI=1S/C21H35NO3Si/c1-21(2,3)26(5,6)25-19-13-16-11-15(12-17(16)18(19)14-22)9-7-8-10-20(23)24-4/h12,16-19H,7-11,13H2,1-6H3/t16-,17-,18+,19+/m1/s1 |
| InChIKey | QYMZISNEBSUGRM-YRXWBPOGSA-N |
| Mol Weight | 377.6 g/mol |
| Molecular Formula | C21H35NO3Si |
| Exact Mass | 377.238621 g/mol |
| Enantiomer InChIKey | QYMZISNEBSUGRM-INDMIFKZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,3AR,5R,6R,6AS)-6-ALLYL-5-[[TERT.-BUTYL-(DIPHENYL)-SILYL]-OXY]-1-METHYLHEXAHYDROPENTALEN-2(1H)-ONE
(1S,4aR,8S,8aS)-8-[tert-butyl(dimethyl)silyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid methyl ester
8-(tert-Butyldimethylsiloxy)-8,9-di(hydroxymethyl)bicyclo[4.3.0]nonane
DMIPS-ether of prostaglandin D2-methyl ester
DMIPS-ether of prostaglandin F-2.alpha.-methyl ester
5.alpha.,7.alpha.,16-Trihydroxy-11-oxotetranor-prostanoic acid methyl ester tert-butyldimethylsilyl ether
DMES-ether of prostaglandin F-2.alpha.-methyl ester
[2-{4'-(Formylhexahydro-5-[(tetrahydro-2H-pyran-2"-yl)oxy]-(1H)-pentanylidene]ethoxy}-1,1-dimethylethyl acetate
(15R/S)-9,11-O-DI-(TRIETHYLSILYL)-5,6-DEHYDRO-15-F(2T)-ISOP-METHYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| Stereocontrol in organic synthesis using silicon-containing compounds. A synthesis of a (±)-carbacyclin analogue with the geometry of the exocyclic double bond controlled by the protodesilylation of an allylsilane | Journal of the Chemical Society, Perkin Transactions 1 | 1998 |